Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
7(70%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
10%
Ph phase_4
1
10%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

10

all time

Status Distribution
Active(7)
Completed(2)
Other(1)

Detailed Status

Recruiting6
Completed2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
7
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

active_not_recruiting110%
completed220%
recruiting660%
unknown110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10